Skip to Main Content

Author Details

Diana Abbott
Center for Innovative Design and Analysis, University of Colorado, Aurora CO.
2008
48
19
PMIDPaper TitleJournal TitlePublished Year
36335021Clinical and Radiographic Predictors of Progression and Survival in Relapsed/Refractory Lymphoma Patients Receiving Anti-CD19 CAR T-cell Therapy.Clin Lymphoma Myeloma Leuk2023
37648670CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies.Blood Adv2023
37051756Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia.Haematologica2023
34250757Evaluation and associated risk factors for neutropenia with venetoclax and obinutuzumab in the treatment of chronic lymphocytic leukemia.Cancer Rep (Hoboken)2022
35403671ABO Blood Groups Are Not Associated With COVID-19 Disease Incidence and Severity When Correcting for Ethnicity Differences in Blood Type.Am J Clin Pathol2022
35618765Quality of life following cord blood versus matched sibling donor transplantation: pre-transplantation psychiatric and socioeconomic factors significantly impact outcomes.Bone Marrow Transplant2022
35902048Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax + Azacitidine Versus Intensive Chemotherapy.Transplant Cell Ther2022
36225746Incidence of Invasive Fungal Infections in Patients With Previously Untreated Acute Myeloid Leukemia Receiving Venetoclax and Azacitidine.Open Forum Infect Dis2022
34645926Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60.Bone Marrow Transplant2022
33375853The propriety of upgrading responses to venetoclaxâ¿¿+â¿¿azacitidine in newly diagnosed patients with acute myeloid leukemia.Leuk Lymphoma2021
34610123Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia.Blood Adv2021
31526057Why do patients come to the emergency department after using cannabis?Clin Toxicol (Phila)2020
33884374Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells.Nat Cancer2020
31974170Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia.Cancer Discov2020
31761712Evaluating Novel PET-CT Functional Parameters TLG and TMTV in Differentiating Low-grade Versus Grade 3A Follicular Lymphoma.Clin Lymphoma Myeloma Leuk2020
33033675Thirty-Day Outcomes From Standalone Minimally Invasive Surgery-Transforaminal Lumbar Interbody Fusion Patients in an Ambulatory Surgery Center vs. Hospital Setting.Cureus2020
32822582Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells.Cell Stem Cell2020
32311014Measurement of ex vivo resistance to proteasome inhibitors, IMiDs, and daratumumab during multiple myeloma progression.Blood Adv2020
30661538Emergency Physicians and Firearms: Effects of Hands-on Training.Ann Emerg Med2019
31670911Increased risk for other cancers in individuals with Ewing sarcoma and their relatives.Cancer Med2019
31648312Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia.Blood Adv2019
31527947Acute Illness Associated with Cannabis Use, by Route of Exposure: An Observational Study.Mo Med2019
31009835Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysis.Leuk Res2019
30909297Acute Illness Associated With Cannabis Use, by Route of Exposure: An Observational Study.Ann Intern Med2019
30823903The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database.BMC Cancer2019
30632821Cellular proliferation by multiplex immunohistochemistry identifies aggressive disease behavior in relapsed multiple myeloma.Leuk Lymphoma2019
28156254Population-based description of familial clustering of Chiari malformation Type I.J Neurosurg2018
29882961CYP2D6 Genotype Phenotype Discordance Due to Drug-Drug Interaction.Clin Pharmacol Ther2018
30420752Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia.Nat Med2018
28764811Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy.J Transl Med2017
28095098Reduced penetrance in a large Caucasian pedigree with Stickler syndrome.Ophthalmic Genet2017
28468799PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.Blood2017
28369832A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.Cancer2017
28538557Safety of Outpatient Circumferential Body Lift: Evidence from 42 Consecutive Cases.Plast Reconstr Surg2017
28721883Patterns of Care for Patients With Early-Stage Glottic Cancer Undergoing Definitive Radiation Therapy: A National Cancer Database Analysis.Int J Radiat Oncol Biol Phys2017
27064430A population-based survey of risk for cancer in individuals diagnosed with myotonic dystrophy.Muscle Nerve2016
27170569Population-based risks for cancer in patients with ALS.Neurology2016
26172955Relative risks for comorbidities associated with myotonic dystrophy: A population-based analysis.Muscle Nerve2015
24058921Quantitative trait locus linkage analysis in a large Amish pedigree identifies novel candidate loci for erythrocyte traits.Mol Genet Genomic Med2013
30227522Cycle Time Metrics for Multisite Clinical Trials in the United States.Ther Innov Regul Sci2013
22509102An international collaborative family-based whole genome quantitative trait linkage scan for myopic refractive error.Mol Vis2012
20435602Genetic association of insulin-like growth factor-1 polymorphisms with high-grade myopia in an international family cohort.Invest Ophthalmol Vis Sci2010
20616172A new locus for familial FSGS on chromosome 2p.J Am Soc Nephrol2010
19471602Hepatocyte growth factor and myopia: genetic association analyses in a Caucasian population.Mol Vis2009
19387081COL1A1 and COL2A1 genes and myopia susceptibility: evidence of association and suggestive linkage to the COL2A1 locus.Invest Ophthalmol Vis Sci2009
19324860An international collaborative family-based whole-genome linkage scan for high-grade myopia.Invest Ophthalmol Vis Sci2009
17849491A principal components regression approach to multilocus genetic association studies.Genet Epidemiol2008
18434968VWD type 1: a calculated diagnosis.Blood2008
  • 1 - 48 of 48

Recommended Authors

Matthew A Hathcock
Mayo Clinic
Career Start Year 2013
Number of shared co-authors 0
Tristan Grogan
University of California Los Angeles
Career Start Year 2013
Number of shared co-authors 0
Martin Goros
University of Texas Health San Antonio
Career Start Year 2013
Number of shared co-authors 0
Yunfeng Dai
Colleges of Medicine, University of Florida
Career Start Year 2009
Number of shared co-authors 2
Jill Hardin
Janssen Pharmaceutical Research and Development
Career Start Year 2009
Number of shared co-authors 0
Jaeil Ahn
Georgetown University
Career Start Year 2008
Number of shared co-authors 1
Matthieu Resche-Rigon
Universite Paris-Cite, INSERM
Career Start Year 2006
Number of shared co-authors 0
Mengling Liu
NYU Grossman School of Medicine
Career Start Year 2005
Number of shared co-authors 0
Jiang Gui
Geisel School of Medicine at Dartmouth
Career Start Year 2004
Number of shared co-authors 0
Keyue Ding
Queen's University
Career Start Year 2002
Number of shared co-authors 0
Gregory D Jenkins
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 0
Soledad Fernandez
McGill University
Career Start Year 2001
Number of shared co-authors 0
Dexiang Gao
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 6
Ronghui Xu
University of California San Diego
Career Start Year 2000
Number of shared co-authors 0
Mi-Ok Kim
University of California san francisco
Career Start Year 2000
Number of shared co-authors 0
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
Chi-Hong Tseng
David Geffen School of Medicine, University of California los angeles
Career Start Year 1998
Number of shared co-authors 0
David Elashoff
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 0
Manisha Desai
Stanford University
Career Start Year 1997
Number of shared co-authors 0
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 1
Borko Jovanovic
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 2
Wei Xu
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 1
Ruth M Pfeiffer
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 0
Motomi Mori
St Jude Children's Research Hospital.
Career Start Year 1988
Number of shared co-authors 6
Rebecca A Betensky
New York University.
Career Start Year 1987
Number of shared co-authors 0
Terry M Therneau
Mayo Clinic
Career Start Year 1986
Number of shared co-authors 0
Brad H Pollock
University of California davis
Career Start Year 1983
Number of shared co-authors 0
Judith D Goldberg
NYU Grossman School of Medicine
Career Start Year 1974
Number of shared co-authors 0
Jeffrey P Krischer
Health Informatics Institute, University of South Florida
Career Start Year 1971
Number of shared co-authors 0

Collaborators

Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 12
Veronica Clavijo Jordan
Harvard Medical School
Co-authored papers 12
Amanda Winters
University of Colorado School of Medicine
Co-authored papers 11
Clayton A Smith
University of Colorado, Aurora CO.
Co-authored papers 11
Brett M Stevens
University of Colorado School of Medicine
Co-authored papers 9
Shanshan Pei
Zhejiang University Medical Center
Co-authored papers 6
Terri L Young
Co-authored papers 6
Mohammad Minhajuddin
University of Colorado School of Medicine
Co-authored papers 6
Maria Amaya
University of Colorado School of Medicine
Co-authored papers 5
Yi-Ju Li
Duke University School of Medicine
Co-authored papers 5
David A Mackey
Lions Eye Institute, University of Western Australia
Co-authored papers 4
Angelo D'Alessandro
University of Colorado Anschutz Medical Campus
Co-authored papers 4
Courtney L Jones
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Rachel Culp-Hill
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Haobin Ye
Institute of Metabolism & Integrative Biology, Fudan University
Co-authored papers 3
Anagha Inguva
University of Colorado School of Medicine
Co-authored papers 3
Anna Krug
University of Colorado School of Medicine
Co-authored papers 3
Sana D Karam
University of Colorado School of Medicine
Co-authored papers 3
Andy Phan
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Travis Nemkov
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Co-authored papers 2
Michael J Owen
Co-authored papers 2
Leylah M Drusbosky
College of Medicine, University of Florida
Co-authored papers 1
Howard Colman
Huntsman Cancer Institute, University of Utah
Co-authored papers 1
Elizabeth R Hauser
Duke University School of Medicine
Co-authored papers 1
Julie A Reisz
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Edwin M Stone
Carver College of Medicine, University of Iowa, USA Institute for Vision Research
Co-authored papers 1
Deborah W Neklason
Huntsman Cancer Institute
Co-authored papers 1
Fabia Gamboni
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Annika Gustafson
University of Colorado Denver
Co-authored papers 1
Release 1.2